Astrazeneca delivers 586,700 COVID-19 vaccine doses to MalaysiaJULY 3, 2021 @ 1.41PM
(Left) Dr Sanjeev Panchal, Country President of AstraZeneca Malaysia handing over 586,700 doses of AstraZeneca COVID-19 vaccine to (centre) Dato' Sri Dr Adham Baba, Minister of Health and Datuk Harjeet Singh, Deputy Head Secretary, Ministry of Health.
AstraZeneca has delivered 586,700 doses of its COVID-19 vaccine for use in Malaysia. The first batch of shipment from Thailand, which is part of AstraZeneca’s commitment to deliver 6.4 million doses directly to Malaysia in addition to the delivery of millions more doses through COVAX and donations from third countries.
A total of 2,414,700 doses of the vaccine have now been delivered to date. The delivery was officially handed over to Dato’ Sri Dr Adham Baba, Minister of Health and Datuk Harjeet Singh, Deputy Head Secretary, Ministry of Health to mark the milestone. The doses will support the National Immunisation Programme’s mass vaccination spearheaded by the Ministry of Health. Dr Sanjeev Panchal, Country President, AstraZeneca Malaysia, said: “The delivery is an important milestone in the battle against the pandemic. We look forward to continued cooperation with the government and others working to support Malaysia’s recovery from this devastating pandemic.” AstraZeneca’s COVID-19 vaccine has been shown to be well-tolerated and highly effective against all disease severities across all adults in clinical trials, and emerging real-world evidence from tens of millions of people also shows that the vaccine reduces severe disease and hospital admissions by more than 80% after the first dose. The vaccine has also demonstrated a high level of protection against the delta and alpha variants, including being 92% effective against hospitalisation due to the delta variant. AstraZeneca continues to supply its COVID-19 vaccine globally at no profit during the pandemic. |
EXPLORE FURTHER
|
Pharmacy cautions against self-medication and self-dosing of 'Ivermectin' to treat COVID-19No human use of Ivermectin is approved or registered in Malaysia
|
|
Could a single dose of the drug Ivermectin stop the SARS-COV-2 virus from growing?Ivermectin removed all viral RNA by 48 hours
|
|
The Malaysian response to Covid-19: Building preparedness for ‘surge capacity’, testing efficiency and containmentEarly coordination key to Malaysia's COVID-19 response success
|
|
Is it sinusitis or Covid-19?How COVID-19 symptoms differ from sinusitis: Key insights
|
|
Covid-19: The legal implications of patients' lack of honestyHow can we legally encourage patients to share critical information?
|
|
Road to recovery: Care after COVID-19Understanding post-acute Sequelae of SARS-CoV-2 infection in patients
|
